Clearday, Inc. (CLRD)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 12.48 Million USD | -3.05% |
| 2021 | 12.88 Million USD | 1.79% |
| 2020 | 12.65 Million USD | 2222.12% |
| 2019 | 545 Thousand USD | -99.96% |
| 2018 | 1.55 Billion USD | 248.88% |
| 2017 | 446 Million USD | 340358.02% |
| 2016 | 131 Thousand USD | -46.31% |
| 2015 | 244 Thousand USD | -99.96% |
| 2014 | 632 Million USD | -63.04% |
| 2013 | 1.71 Billion USD | -47.17% |
| 2012 | 3.23 Billion USD | 94659.95% |
| 2011 | 3.41 Million USD | -49.53% |
| 2010 | 6.76 Million USD | -61.76% |
| 2009 | 17.69 Million USD | -99.74% |
| 2008 | 6.76 Billion USD | -47.07% |
| 2007 | 12.78 Billion USD | -27.74% |
| 2006 | 17.69 Billion USD | -16.05% |
| 2005 | 21.08 Billion USD | 25.57% |
| 2004 | 16.78 Billion USD | -56.48% |
| 2003 | 38.57 Billion USD | 119.18% |
| 2002 | 17.6 Billion USD | 131.56% |
| 2001 | 7.6 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 619.03 Thousand USD | -79.41% |
| 2023 Q1 | 3 Million USD | -2.56% |
| 2023 Q3 | 831.9 Thousand USD | 34.39% |
| 2022 Q4 | 3.08 Million USD | 0.92% |
| 2022 FY | 12.48 Million USD | -3.05% |
| 2022 Q3 | 3.05 Million USD | -2.5% |
| 2022 Q1 | 3.21 Million USD | 7.44% |
| 2022 Q2 | 3.13 Million USD | -2.33% |
| 2021 Q4 | 2.98 Million USD | 4.79% |
| 2021 FY | 12.88 Million USD | 1.79% |
| 2021 Q1 | 3.74 Million USD | 11.78% |
| 2021 Q2 | 3.29 Million USD | -11.91% |
| 2021 Q3 | 2.85 Million USD | -13.54% |
| 2020 Q2 | - USD | -100.0% |
| 2020 Q1 | 184 Million USD | -52.58% |
| 2020 Q4 | 3.34 Million USD | 27.03% |
| 2020 Q3 | 2.63 Million USD | 0.0% |
| 2020 FY | 12.65 Million USD | 2222.12% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q4 | 388 Million USD | 147.13% |
| 2019 FY | 545 Thousand USD | -99.96% |
| 2019 Q1 | - USD | -100.0% |
| 2019 Q3 | 157 Million USD | 0.0% |
| 2018 Q3 | 517 Million USD | 140389.13% |
| 2018 Q1 | 246 Million USD | -49.8% |
| 2018 Q4 | 792.63 Million USD | 53.31% |
| 2018 Q2 | 368 Thousand USD | -99.85% |
| 2018 FY | 1.55 Billion USD | 248.88% |
| 2017 FY | 446 Million USD | 340358.02% |
| 2017 Q2 | - USD | 100.0% |
| 2017 Q1 | -66 Million USD | 35.84% |
| 2017 Q4 | 490 Million USD | 0.0% |
| 2016 FY | 131 Thousand USD | -46.31% |
| 2016 Q3 | 22 Million USD | 100.0% |
| 2016 Q4 | -102.86 Million USD | -567.59% |
| 2016 Q2 | 11 Million USD | -84.29% |
| 2016 Q1 | 70 Million USD | 132.29% |
| 2015 Q1 | 55 Million USD | -32.93% |
| 2015 Q3 | 91 Million USD | 28.17% |
| 2015 FY | 244 Thousand USD | -99.96% |
| 2015 Q4 | -216.75 Million USD | -338.19% |
| 2015 Q2 | 71 Million USD | 29.09% |
| 2014 Q4 | 82 Million USD | -4.65% |
| 2014 Q2 | 75 Million USD | -80.72% |
| 2014 Q1 | 389 Million USD | -40.15% |
| 2014 FY | 632 Million USD | -63.04% |
| 2014 Q3 | 86 Million USD | 14.67% |
| 2013 Q3 | 229 Million USD | -58.74% |
| 2013 Q4 | 650 Million USD | 183.84% |
| 2013 FY | 1.71 Billion USD | -47.17% |
| 2013 Q2 | 555 Million USD | 101.09% |
| 2013 Q1 | 276 Million USD | -90.27% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | 399 Million USD | 175.98% |
| 2012 Q2 | - USD | -100.0% |
| 2012 FY | 3.23 Billion USD | 94659.95% |
| 2012 Q4 | 2.83 Billion USD | 0.0% |
| 2011 Q3 | 1.56 Million USD | 0.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 527 Million USD | 110.24% |
| 2011 Q4 | -525.14 Million USD | -33698.66% |
| 2011 FY | 3.41 Million USD | -49.53% |
| 2010 Q1 | 3.41 Billion USD | 171.98% |
| 2010 Q4 | -5.14 Billion USD | 0.0% |
| 2010 FY | 6.76 Million USD | -61.76% |
| 2010 Q3 | - USD | -100.0% |
| 2010 Q2 | 1.73 Billion USD | -49.11% |
| 2009 Q3 | 2.98 Billion USD | 67.98% |
| 2009 Q4 | -4.74 Billion USD | -258.94% |
| 2009 FY | 17.69 Million USD | -99.74% |
| 2009 Q1 | - USD | -100.0% |
| 2009 Q2 | 1.77 Billion USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | 6.76 Billion USD | 0.0% |
| 2008 FY | 6.76 Billion USD | -47.07% |
| 2008 Q1 | - USD | -100.0% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q4 | 10.11 Billion USD | 0.0% |
| 2007 FY | 12.78 Billion USD | -27.74% |
| 2007 Q1 | -982 Million USD | -116.72% |
| 2007 Q2 | 3.65 Billion USD | 472.0% |
| 2006 Q2 | 3.93 Billion USD | -18.76% |
| 2006 Q4 | 5.87 Billion USD | 0.0% |
| 2006 FY | 17.69 Billion USD | -16.05% |
| 2006 Q1 | 4.84 Billion USD | -20.56% |
| 2005 Q4 | 6.09 Billion USD | 99.64% |
| 2005 Q3 | 3.05 Billion USD | -59.74% |
| 2005 Q2 | 7.58 Billion USD | 74.12% |
| 2005 Q1 | 4.35 Billion USD | 45.18% |
| 2005 FY | 21.08 Billion USD | 25.57% |
| 2004 FY | 16.78 Billion USD | -56.48% |
| 2004 Q2 | 4.55 Billion USD | 43.01% |
| 2004 Q3 | 6.05 Billion USD | 32.97% |
| 2004 Q1 | 3.18 Billion USD | -89.26% |
| 2004 Q4 | 2.99 Billion USD | -50.45% |
| 2003 Q3 | 11.57 Billion USD | 29.43% |
| 2003 Q2 | 8.93 Billion USD | 0.0% |
| 2003 FY | 38.57 Billion USD | 119.18% |
| 2003 Q4 | 29.63 Billion USD | 156.16% |
| 2003 Q1 | - USD | -100.0% |
| 2002 Q2 | 5.27 Billion USD | 42.3% |
| 2002 FY | 17.6 Billion USD | 131.56% |
| 2002 Q4 | 4.3 Billion USD | -0.02% |
| 2002 Q3 | 4.31 Billion USD | -18.29% |
| 2002 Q1 | 3.7 Billion USD | 0.0% |
| 2001 FY | 7.6 Billion USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | 1.17 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| The Amacore Group, Inc. | 28.82 Million USD | 56.682% |
| Arem Pacific Corporation | 343.47 Thousand USD | -3535.899% |
| Assisted 4 Living, Inc. | 880.78 Thousand USD | -1317.894% |
| BioCorRx Inc. | 89.16 Thousand USD | -13906.899% |
| Bionik Laboratories Corp. | 1.8 Million USD | -591.809% |
| Banyan Corp. | 5 Million USD | -149.587% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -284.736% |
| Quantum Medical Transport, Inc. | 1310.14 USD | -953122.633% |
| Empower Clinics Inc. | 4.66 Million USD | -167.907% |
| First Choice Healthcare Solutions, Inc. | 29.98 Thousand USD | -41549.328% |
| Selectis Health, Inc. | 36.78 Million USD | 66.048% |
| Ethema Health Corporation | 5.34 Million USD | -133.65% |
| HealthLynked Corp. | 5.72 Million USD | -118.241% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.24 Million USD | -35.029% |
| JRSIS Health Care Corporation | 3.46 Million USD | -260.739% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 453.75 Million USD | 97.248% |
| MedSmart Group Inc. | - USD | -Infinity% |
| North America Frac Sand, Inc. | 137.3 Thousand USD | -8995.482% |
| Nova Leap Health Corp. | 26.17 Million USD | 52.296% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -3451.284% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -18.92% |
| Raffles Medical Group Ltd | 536.52 Million USD | 97.672% |
| Ryman Healthcare Limited | 650.53 Million USD | 98.08% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 4.61 Million USD | -170.692% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | - USD | -Infinity% |
| Veltex Corporation | 838.65 Thousand USD | -1389.118% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 1.12 Million USD | -1012.977% |